Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia
- 31 July 2005
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 193 (1), 185-191
- https://doi.org/10.1016/j.ajog.2004.11.038
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsiaObstetrics & Gynecology, 2003
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in PregnancyAmerican Journal of Obstetrics and Gynecology, 2000
- The myths of laparoscopic surgeryAmerican Journal of Obstetrics and Gynecology, 2000
- Endothelial Dysfunction in PreeclampsiaSeminars in Reproductive Medicine, 1998
- Placental Cytokines and the Pathogenesis of PreeclampsiaAmerican Journal of Reproductive Immunology, 1997
- Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Uteroplacental and luteal circulation in normal first-trimester pregnancies: Doppler ultrasonographic and morphologic studyAmerican Journal of Obstetrics and Gynecology, 1996
- Neonatal outcome after preterm delivery for preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1995
- Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the CaribbeanBJOG: An International Journal of Obstetrics and Gynaecology, 1992